---
title: "AYTU: EXXUA launch drives growth in CNS therapeutics, with FY26 revenue at $66.4M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299813775.md"
description: "Focused on CNS therapeutics, the company launched EXXUA for MDD, targeting a $22B+ market with a differentiated profile. FY26 net revenue reached $66.4M, supported by strong ADHD and pediatric brands, robust commercial infrastructure, and a scalable launch strategy.Original document: Aytu BioPharma, Inc. [AYTU] Slides Release — Sep. 22 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-09-22T21:09:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299813775.md)
  - [en](https://longbridge.com/en/news/299813775.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299813775.md)
generator: "portal-rs"
---

# AYTU: EXXUA launch drives growth in CNS therapeutics, with FY26 revenue at $66.4M

Focused on CNS therapeutics, the company launched EXXUA for MDD, targeting a $22B+ market with a differentiated profile. FY26 net revenue reached $66.4M, supported by strong ADHD and pediatric brands, robust commercial infrastructure, and a scalable launch strategy.

Original document: Aytu BioPharma, Inc. \[AYTU\] Slides Release — Sep. 22 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [AYTU.US](https://longbridge.com/en/quote/AYTU.US.md)

## Related News & Research

- [Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales](https://longbridge.com/en/news/299809035.md)
- [Aytu Fiscal Q4 2026 Earnings: EXXUA Drives Revenue Growth](https://longbridge.com/en/news/299813680.md)
- [Palantir Makes Surprising Push Into AI Market Governments Increasingly Want](https://longbridge.com/en/news/300793024.md)
- [Time to Nibble on MCD Stock After it Enters Oversold Territory?](https://longbridge.com/en/news/300812314.md)
- [2 of the Best Warren Buffett Stocks for a Lifetime of Passive Income](https://longbridge.com/en/news/300803278.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**